Careers  |  Sign In  |  Register  |   Twitter

Latest in Family Medicine

Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related matters.
An experimental women’s libido drug, flibanserin, developed by Sprout Pharmaceuticals, has been advised for rejection by the FDA advisory panel, according to Reuters. Flibanserin is a selective serotonin reuptake inhibitor (SSRI) and was initially tested as an antidepressant. After it was found to be an...
The Doctor's Channel has partnered with ReelDX to bring you a new video case each week. Take the challenge to see if you can you diagnose this patient's condition.